Urethritis Market Dynamics, Top Manufacturers Analysis, Trend And Demand, Forecast To 2023
The study report Global Urethritis Market covers the market analysis for the regions - North America, Europe, Asia Pacific/ Southeast Asia and RoW and country analysis of China, Japan, and India focusing on top manufacturers in global market and the market share they hold including their contribution to the market growth The global Urethritis Market is expected to reach USD 18.0 billion by 2023 at a CAGR of ~ 8.0 % during the forecast period 2017-2023. Key Market Players Major key players profiled in the report are F. Hoffmann-La Roche AG, GlaxoSmithKline, AbbVie, Johnson & Johnson, and Merck & Co., Eli Lilly and Company, Bristol-Myers Squibb Company, Bayer AG, and AstraZeneca plc., and others. Urethritis is inflammation of the urethra, or the tube that carries urine. The symptoms include burning sensation while urinating, presence of blood in the semen or urine, frequent urge and discomfort while urinating, abnormal discharge from the vagina or penis, etc. Untreat...
Comments
Post a Comment